News & Updates

Using data from the ongoing population-based Tromsø study, baseline obesity was found to be associated with an increased risk of prefrailty/frailty in later years.

The use of sodium-glucose transporter 2 (SGLT2) inhibitors among patients with diabetes does not pose an increased risk of developing fractures as compared with dipeptidyl-peptidase 4 (DPP4) inhibitors, and this is true across estimated glomerular filtration rate (eGFR) and albuminuria categories, as shown in a study.

Paediatricians and other healthcare providers should treat childhood obesity immediately and at the highest level of intensity appropriate for and available to children, according to the new guideline published by the American Academy of Pediatrics (AAP).

Initiation of a glucagon-like peptide-1 (GLP-1) agonist at standard glycaemic control doses may result in modest weight loss through 72 weeks in patients with overweight or obesity and type 2 diabetes, suggest the results of a real-world study.

Almond consumption led to improvements in cardiometabolic, glycaemic, and insulin markers in Asian Indian adults with overweight and obesity, a study has shown.

Notable phenotypic differences are present in patients with pituitary stalk interruption syndrome (PSIS) who are overweight or obese, which indicate hypothalamic defects, reports a study.

Boys with sustained exposure to secondhand smoke are at increased risk of obesity, as reported in a study.

Reduced muscle strength (dynapenia) is associated with a higher risk of leg and ankle fractures in women with obesity, as shown in a study. Dynapenia also negates the protective effects of obesity on fractures of the wrist, arm, hip, spine, and other bones, thus increasing the risk of falls.

Children diagnosed with asthma between ages 5 and 7 years may have an increased risk of developing type 1 diabetes (T1D) and inflammatory bowel diseases (IBD; Crohn’s disease and ulcerative colitis), a Danish nationwide registry study suggests.